openPR Logo
Press release

United States 3D Bioprinting Market to Reach 26.87 billion by 2033, Led by Organovo, CELLINK, and Allevi | DataM Intelligence

10-16-2025 11:35 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

3D Bioprinting Market

3D Bioprinting Market

The global 3D Bioprinting Market reached USD 3.45 billion in 2024 and is projected to reach USD 26.87 billion by 2033, growing at a CAGR of 26.5% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, Organovo successfully bioprinted functional liver tissue for drug testing, reducing animal testing reliance.
✅ In October 2025, The FDA released new regulatory guidelines for 3D-bioprinted tissues and organ-assist devices.
✅ In October 2025, A US research consortium bioprinted patient-specific bone grafts for complex orthopedic reconstructions.

Japan: Recent Industry Developments

✅ In October 2025, Cyfuse Biomedical launched a new robotic bioprinting platform for high-throughput tissue fabrication.
✅ In October 2025, Japan's Regenerative Medicine Act was amended to fast-track approval for 3D-bioprinted therapeutic products.
✅ In October 2025, A Tokyo University team bioprinted corneal tissue for transplantation, addressing donor shortages.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/3d-bioprinting-market?jd

Market Trends & Drivers

The 3D Bioprinting Market is advancing rapidly, driven by innovations in bioinks, increased R&D funding, and the growing need for organ transplants. Key trends include the development of multi-material bioprinters, vascularization of engineered tissues, and the use of patient-specific cells. The rising prevalence of chronic diseases, advancements in stem cell research, and supportive government initiatives are accelerating the adoption of 3D bioprinting in regenerative medicine and drug discovery.

Competitive Landscape

The market includes specialized bioprinting firms, academic research institutions, and medical companies.

Organovo Holdings, Inc. pioneers 3D bioprinting for functional human tissues for research and therapeutic applications.
CELLINK (BICO) provides bioprinters, bioinks, and services, serving research and pharmaceutical sectors globally.
Allevi (3D Systems) offers desktop bioprinters and bioinks tailored for researchers and educators.
RegenHU Ltd. develops advanced 3D bioprinting platforms for tissue engineering and regenerative medicine.
Aspect Biosystems Ltd. focuses on therapeutic tissue and organ bioprinting using proprietary technology.
Poietis specializes in laser-assisted bioprinting for high-resolution tissue fabrication.
Cyfuse Biomedical K.K. develops robotic bioprinting systems for assembling cellular spheroids into tissues.
nScrypt, Inc. manufactures precision bioprinters for complex tissue structures and organoids.
Advanced Solutions Life Sciences offers the BioAssemblyBot for automated tissue and organ modeling.
ROKIT Healthcare Inc. provides consumer and clinical-grade bioprinters for skin and tissue regeneration.

Segmentation

By Component (3D Printers, Biomaterials, Scaffolds)
By Technology (Inkjet-Based Bioprinting, Magnetic Levitation, Syringe-Based Bioprinting, Laser-Based Bioprinting, Others)
By Application (Tissue and Organ Generation, Medical Pills, Prosthetics and Implants, Dental, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Products)
By End-User (Research Organizations and Academic Institutes, Biopharmaceutical Companies, Hospitals, Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/3d-bioprinting-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.

Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States 3D Bioprinting Market to Reach 26.87 billion by 2033, Led by Organovo, CELLINK, and Allevi | DataM Intelligence here

News-ID: 4227107 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Vaccine Delivery Devices Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Vaccine Delivery Devices Market 2025 | Growth Drivers, Trends & Ma …
Market Size and Growth Vaccine Delivery Devices Market is expected to grow at a CAGR of 7.2% during the forecast period 2024-2031 Key Development: United States: Recent Industry Developments ✅ In September 2025, Vaxxas commenced clinical trials for its High-Density Microarray Patch (HD-MAP) technology. This needle-free skin patch delivers vaccines directly to immune cells beneath the skin surface, potentially revolutionizing vaccine delivery methods. ✅ In August 2025, AstraZeneca introduced FluMist Home, a needle-free nasal spray
United States Breast Aesthetic Surgery Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities
United States Breast Aesthetic Surgery Market 2025 | Growth Drivers, Competitive …
MARKET SIZE AND GROWTH Breast Aesthetic Surgery Market is expected to grow at a CAGR of 8.5% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments in Breast Aesthetic Surgery ✅ In October 2025 - Motiva introduced "Preservé," a minimally invasive breast augmentation technique emphasizing tissue preservation and rapid recovery. Utilizing ultrasound-guided balloon dilation and SmoothSilk Ergonomix implants, it offers subtle volume enhancement with reduced scarring and discomfort. ✅ In October
United States Medical Grade Silicone Market 2025 | Growth Drivers, Competitive Landscape & Business Opportunities
United States Medical Grade Silicone Market 2025 | Growth Drivers, Competitive L …
Market Size and Growth Medical Grade Silicone Market size was valued at US$ 1,587.61 million in 2022 and is estimated to reach US$ 2,285.39 million by 2031, growing at a CAGR of 5.84% during the forecast period (2024-2031). Key Development: United States: Recent Industry Developments ✅ In October 2025, Motiva announced the upcoming U.S. launch of "Preservé," a minimally invasive breast augmentation technique utilizing SmoothSilk Ergonomix silicone implants. This method aims to reduce
United States Pet Obesity Management Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities
United States Pet Obesity Management Market 2025 | Growth Drivers, Competitive L …
Market Size and Growth The global pet obesity management market is experiencing unprecedented growth as awareness of pet health escalates worldwide. With the global market reaching US$ 1.7 billion in 2023 and projected to attain US$ 3.1 billion by 2031, growing at a CAGR of 6.8% during 2024-2031, this sector is becoming a focal point for veterinary care providers, pet nutrition companies, and pet owners alike. The rise in pet obesity,

All 5 Releases


More Releases for Bioprinting

Prominent 4D Bioprinting Market Trend for 2025: Strategic Partnerships Drive Inn …
Which drivers are expected to have the greatest impact on the over the 4d bioprinting market's growth? The surge in the need for organ transplants is anticipated to fuel the expansion of the 4D bioprinting market. Organ transplants entail the surgical removal of an organ or tissue from an individual (the donor) and transferring it to another person (the recipient) who requires the organ due to organ failure or disorder. Lifesaving
3D Bioprinting Market: Research Methodology and Scope
The 3D Bioprinting Market size was valued at USD 1.39 Bn. in 2022 and the total revenue is expected to grow by 20.07% from 2023 to 2029, reaching nearly USD 5.01 Bn. 3D Bioprinting Market Market Report Scope and Research Methodology Report Scope: The Maximize Market Research Pvt Ltd report offers an extensive examination of the global 3D Bioprinting Market, predicting its growth in terms of USD value from 203 to 2029.
3D Bioprinting Market Growth Probability, Leading Vendors and Future Scenario Du …
An influential 3D Bioprinting Market report is the most suitable solution for the business requirements in many ways. The report aids in achieving an extreme sense of evolving industry movements before the competitors. The report also covers market overview, premium insights, key insights and company profiles in detail of the key market players. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s
3D Bioprinting Market: Future of Bioprinting, it is Creating Real Change in the …
The growth of the 3D bioprinting market is mainly driven by the technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities, especially in emerging markets, which are expected to witness the highest growth. The 3D
Bioprinting Global Market 2018: Key Players – 3D BIO CORP., 3D BIOPRINTING SOL …
Bioprinting Industry Description Wiseguyreports.Com Adds “Bioprinting -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database 3-D printers are beginning to revolutionize the manufacturing industry and are now increasingly used to make finished parts and goods. This industry is reshaping traditional supply chains and is enabling localization and customization in the manufacturing sector. Bioprinting is related to 3-D printing but uses living cells as well as
3D Bioprinting market : Global Overview 2022
Research Trades adds a new report package “3D Bioprinting market- Size, Share, Trends, Forecast, Growth 2022” In this report, the global 3D Bioprinting market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market